{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Malaria", "Mitomycin", "Pan-inhibition", "Plasmodium falciparum", "Structure-based drug discovery", "tRNA synthetases"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38805932", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "08"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "08"}, "Article": {"Language": ["eng"], "ELocationID": ["100548", "10.1016/j.ijpddr.2024.100548", "S2211-3207(24)00029-0"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "20"}], "Journal": {"ISSN": "2211-3207", "JournalIssue": {"Volume": "25", "PubDate": {"Year": "2024", "Month": "Aug"}}, "Title": "International journal for parasitology. Drugs and drug resistance", "ISOAbbreviation": "Int J Parasitol Drugs Drug Resist"}, "ArticleTitle": "Repurposing DrugBank compounds as potential Plasmodium falciparum class 1a aminoacyl tRNA synthetase multi-stage pan-inhibitors with a specific focus on mitomycin.", "Pagination": {"StartPage": "100548", "MedlinePgn": "100548"}, "Abstract": {"AbstractText": ["Plasmodium falciparum aminoacyl tRNA synthetases (PfaaRSs) are potent antimalarial targets essential for proteome fidelity and overall parasite survival in every stage of the parasite's life cycle. So far, some of these proteins have been singly targeted yielding inhibitor compounds that have been limited by incidences of resistance which can be overcome via pan-inhibition strategies. Hence, herein, for the first time, we report the identification and in vitro antiplasmodial validation of Mitomycin (MMC) as a probable pan-inhibitor of class 1a (arginyl(A)-, cysteinyl(C), isoleucyl(I)-, leucyl(L), methionyl(M), and valyl(V)-) PfaaRSs which hypothetically may underlie its previously reported activity on the ribosomal RNA to inhibit protein translation and biosynthesis. We combined multiple in silico structure-based discovery strategies that first helped identify functional and druggable sites that were preferentially targeted by the compound in each of the plasmodial proteins: Ins1-Ins2 domain in Pf-ARS; anticodon binding domain in Pf-CRS; CP1-editing domain in Pf-IRS and Pf-MRS; C-terminal domain in Pf-LRS; and CP-core region in Pf-VRS. Molecular dynamics studies further revealed that MMC allosterically induced changes in the global structures of each protein. Likewise, prominent structural perturbations were caused by the compound across the functional domains of the proteins. More so, MMC induced systematic alterations in the binding of the catalytic nucleotide and amino acid substrates which culminated in the loss of key interactions with key active site residues and ultimate reduction in the nucleotide-binding affinities across all proteins, as deduced from the binding energy calculations. These altogether confirmed that MMC uniformly disrupted the structure of the target proteins and essential substrates. Further, MMC demonstrated IC<sub>50</sub>\u00a0<\u00a05\u00a0\u03bcM against the Dd2 and 3D7 strains of parasite making it a good starting point for malarial drug development. We believe that findings from our study will be important in the current search for highly effective multi-stage antimalarial drugs."], "CopyrightInformation": "Copyright \u00a9 2024 The Authors. Published by Elsevier Ltd.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda, 6139, South Africa."}], "LastName": "Olotu", "ForeName": "Fisayo", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antimicrobial & Biocontrol Agents Unit, Laboratory for Phytobiochemistry & Medicinal Plants Studies, Department of Biochemistry, Faculty of Science-University of Yaounde 1, P.O. Box 812, Yaounde, Cameroon; Advanced Research and Health Innovation Hub (ARHIH), Magzi Street, P.O. Box 812, Yaounde, Cameroon."}], "LastName": "Tali", "ForeName": "Mariscal Brice Tchatat", "Initials": "MBT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda, 6139, South Africa."}], "LastName": "Chepsiror", "ForeName": "Curtis", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda, 6139, South Africa."}], "LastName": "Sheik Amamuddy", "ForeName": "Olivier", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antimicrobial & Biocontrol Agents Unit, Laboratory for Phytobiochemistry & Medicinal Plants Studies, Department of Biochemistry, Faculty of Science-University of Yaounde 1, P.O. Box 812, Yaounde, Cameroon; Advanced Research and Health Innovation Hub (ARHIH), Magzi Street, P.O. Box 812, Yaounde, Cameroon."}], "LastName": "Boyom", "ForeName": "Fabrice Fekam", "Initials": "FF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda, 6139, South Africa. Electronic address: o.tastanbishop@ru.ac.za."}], "LastName": "Tastan Bishop", "ForeName": "\u00d6zlem", "Initials": "\u00d6"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int J Parasitol Drugs Drug Resist", "NlmUniqueID": "101576715", "ISSNLinking": "2211-3207"}, "ChemicalList": [{"RegistryNumber": "EC 6.1.1.-", "NameOfSubstance": "Amino Acyl-tRNA Synthetases"}, {"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "50SG953SK6", "NameOfSubstance": "Mitomycin"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Protozoan Proteins"}], "MeshHeadingList": [{"QualifierName": ["drug effects", "enzymology", "genetics"], "DescriptorName": "Plasmodium falciparum"}, {"QualifierName": ["antagonists & inhibitors", "genetics"], "DescriptorName": "Amino Acyl-tRNA Synthetases"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Mitomycin"}, {"QualifierName": [], "DescriptorName": "Drug Repositioning"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["genetics", "metabolism", "antagonists & inhibitors"], "DescriptorName": "Protozoan Proteins"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Apweiler R. The universal protein resource (UniProt) Nucleic Acids Res. 2008;36 doi: 10.1093/NAR/GKM895.", "ArticleIdList": ["10.1093/NAR/GKM895", "PMC540024", "15608167"]}, {"Citation": "Battistello E., Katanayeva N., Dheilly E., Tavernari D., Donaldson M.C., Bonsignore L., Thome M., Christie A.L., Murakami M.A., Michielin O., Ciriello G., Zoete V., Oricchio E. Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma. Blood. 2018;131:2345\u20132356. doi: 10.1182/BLOOD-2017-10-809210.", "ArticleIdList": ["10.1182/BLOOD-2017-10-809210", "PMC5969377", "29567799"]}, {"Citation": "Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., DiNola A., Haak J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984;81:3684\u20133690. doi: 10.1063/1.448118.", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein Data Bank. Nucleic Acids Res. 2000;28:235\u2013242. doi: 10.1093/NAR/28.1.235.", "ArticleIdList": ["10.1093/NAR/28.1.235", "PMC102472", "10592235"]}, {"Citation": "Biovia D.S. Dassault Syst\u00e8mes; San Diego: 2016. Discovery Studio 2016 Client."}, {"Citation": "Burrows J.N., Burlot E., Campo B., Cherbuin S., Jeanneret S., Leroy D., Spangenberg T., Waterson D., Wells T.N.C., Willis P. Antimalarial drug discovery \u2013 the path towards eradication. Parasitology. 2014;141:128. doi: 10.1017/S0031182013000826.", "ArticleIdList": ["10.1017/S0031182013000826", "PMC3884835", "23863111"]}, {"Citation": "Case D.A. University of California; San Francisco: 2018. Amber 18."}, {"Citation": "Case D.A., Cheatham T.E., Darden T., Gohlke H., Luo R., Merz K.M., Onufriev A., Simmerling C., Wang B., Woods R.J. The Amber biomolecular simulation programs. J. Comput. Chem. 2005;26:1668\u20131688. doi: 10.1002/jcc.20290.", "ArticleIdList": ["10.1002/jcc.20290", "PMC1989667", "16200636"]}, {"Citation": "Chakraborti S., Chhibber-Goel J., Sharma A. Drug targeting of aminoacyl-tRNA synthetases in Anopheles species and Aedes aegypti that cause malaria and dengue. Parasites Vectors. 2021;14:1\u201311. doi: 10.1186/S13071-021-05106-5/FIGURES/4.", "ArticleIdList": ["10.1186/S13071-021-05106-5/FIGURES/4", "PMC8665550", "34895309"]}, {"Citation": "Chen I., Hsiang M.S. Triple artemisinin-based combination therapies for malaria: a timely solution to counter antimalarial drug resistance. Lancet Infect. Dis. 2022;22:751\u2013753. doi: 10.1016/S1473-3099(21)00748-9.", "ArticleIdList": ["10.1016/S1473-3099(21)00748-9", "35276063"]}, {"Citation": "Chen C.H., Lin S.K. Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes. BMC Psychiatr. 2012;12:47. doi: 10.1186/1471-244X-12-47.", "ArticleIdList": ["10.1186/1471-244X-12-47", "PMC3410809", "22620289"]}, {"Citation": "Chen B., Luo S., Zhang S., Ju Y., Gu Q., Xu J., Yang X.L., Zhou H. Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase. Nat. Commun. 2021;12 doi: 10.1038/S41467-021-21902-0.", "ArticleIdList": ["10.1038/S41467-021-21902-0", "PMC7955072", "33712620"]}, {"Citation": "Chhibber-Goel J., Yogavel M., Sharma A. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery. Protein Sci. 2021;30:1793\u20131803. doi: 10.1002/PRO.4148.", "ArticleIdList": ["10.1002/PRO.4148", "PMC8376417", "34184352"]}, {"Citation": "Chung S., Kim S., Ryu S.H., Hwang K.Y., Cho Y. Structural basis for the antibiotic resistance of eukaryotic isoleucyl-tRNA synthetase. Mol. Cell. 2020;43:350\u2013359. doi: 10.14348/MOLCELLS.2020.2287.", "ArticleIdList": ["10.14348/MOLCELLS.2020.2287", "PMC7191050", "32088946"]}, {"Citation": "Ecker D.J., Griffey R.H. RNA as a small-molecule drug target: doubling the value of genomics. Drug Discov. Today. 1999;4:420\u2013429. doi: 10.1016/S1359-6446(99)01389-6.", "ArticleIdList": ["10.1016/S1359-6446(99)01389-6", "10461152"]}, {"Citation": "Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577\u20138593. doi: 10.1063/1.470117.", "ArticleIdList": ["10.1063/1.470117"]}, {"Citation": "Flannery E.L., Chatterjee A.K., Winzeler E.A. Antimalarial drug discovery: approaches and progress towards new medicines. Nat. Rev. Microbiol. 2013;11:849. doi: 10.1038/NRMICRO3138.", "ArticleIdList": ["10.1038/NRMICRO3138", "PMC3941073", "24217412"]}, {"Citation": "Forte B., Ottilie S., Plater A., Campo B., Dechering K.J., Gamo F.J., Goldberg D.E., Istvan E.S., Lee M., Lukens A.K., McNamara C.W., Niles J.C., Okombo J., Pasaje C.F.A., Siegel M.G., Wirth D., Wyllie S., Fidock D.A., Baraga\u00f1a B., Winzeler E.A., Gilbert I.H. Prioritization of molecular targets for antimalarial drug discovery. ACS Infect. Dis. 2021;7:2764\u20132776. doi: 10.1021/ACSINFECDIS.1C00322.", "ArticleIdList": ["10.1021/ACSINFECDIS.1C00322", "PMC8608365", "34523908"]}, {"Citation": "Fukai S., Nureki O., Sekine S. ichi, Shimada A., Tao J., Vassylyev D.G., Yokoyama S. Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNA(Val) and valyl-tRNA synthetase. Cell. 2000;103:793\u2013803. doi: 10.1016/S0092-8674(00)00182-3.", "ArticleIdList": ["10.1016/S0092-8674(00)00182-3", "11114335"]}, {"Citation": "Fukai S., Nureki O., Sekine S.I., Shimada A., Vassylyev D.G., Yokoyama S. Mechanism of molecular interactions for tRNAVal recognition by valyl-tRNA synthetase. RNA. 2003;9:100. doi: 10.1261/RNA.2760703.", "ArticleIdList": ["10.1261/RNA.2760703", "PMC1370374", "12554880"]}, {"Citation": "Fukunaga R., Yokoyama S. Aminoacylation complex structures of leucyl-tRNA synthetase and tRNALeu reveal two modes of discriminator-base recognition. Nat. Struct. Mol. Biol. 2005;12:915\u2013922. doi: 10.1038/NSMB985.", "ArticleIdList": ["10.1038/NSMB985", "16155584"]}, {"Citation": "Ghattas M.A., Raslan N., Sadeq A., Sorkhy Al M., Atatreh N. Druggability analysis and classification of protein tyrosine phosphatase active sites. Drug Des. Dev. Ther. 2016;10:3197\u20133209. doi: 10.2147/DDDT.S111443.", "ArticleIdList": ["10.2147/DDDT.S111443", "PMC5053377", "27757011"]}, {"Citation": "Goa K.L., Spencer C.M. Bicalutamide in advanced prostate cancer. A review. Drugs Aging. 1998;12:401\u2013422. doi: 10.2165/00002512-199812050-00006.", "ArticleIdList": ["10.2165/00002512-199812050-00006", "9606617"]}, {"Citation": "Gomez M.A.R., Ibba M. Aminoacyl-tRNA synthetases. RNA. 2020;26:910\u2013936. doi: 10.1261/RNA.071720.119.", "ArticleIdList": ["10.1261/RNA.071720.119", "PMC7373986", "32303649"]}, {"Citation": "Haddad E.B., Patel H., Keeling J.E., Yacoub M.H., Barnes P.J., Belvisi M.G. Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and Guinea-pig airways. Br. J. Pharmacol. 1999;127:413\u2013420. doi: 10.1038/SJ.BJP.0702573.", "ArticleIdList": ["10.1038/SJ.BJP.0702573", "PMC1566042", "10385241"]}, {"Citation": "Halgren T.A. Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model. 2009;49:377\u2013389. doi: 10.1021/ci800324m.", "ArticleIdList": ["10.1021/ci800324m", "19434839"]}, {"Citation": "Hassan N.M., Alhossary A.A., Mu Y., Kwoh C.K. Protein-ligand blind docking using QuickVina-W with inter-process spatio-temporal integration. Sci. Rep. 2017;7 doi: 10.1038/S41598-017-15571-7.", "ArticleIdList": ["10.1038/S41598-017-15571-7", "PMC5684369", "29133831"]}, {"Citation": "Hauenstein S., Zhang C.M., Hou Y.M., Perona J.J. Shape-selective RNA recognition by cysteinyl-tRNA synthetase. Nat. Struct. Mol. Biol. 2004;11:1134\u20131141. doi: 10.1038/NSMB849.", "ArticleIdList": ["10.1038/NSMB849", "15489861"]}, {"Citation": "Herman J.D., Pepper L.R., Cortese J.F., Estiu G., Galinsky K., Zuzarte-Luis V., Derbyshire E.R., Ribacke U., Lukens A.K., Santos S.A., Patel V., Clish C.B., Sullivan W.J., Zhou H., Bopp S.E., Schimmel P., Lindquist S., Clardy J., Mota M.M., Keller T.L., Whitman M., Wiest O., Wirth D.F., Mazitschek R. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target for drug development. Sci. Transl. Med. 2015;7 doi: 10.1126/SCITRANSLMED.AAA3575.", "ArticleIdList": ["10.1126/SCITRANSLMED.AAA3575", "PMC4675670", "25995223"]}, {"Citation": "Hess B., Bekker H., Berendsen H.J.C., Fraaije J.G.E.M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 1997;18:1463\u20131472. doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H.", "ArticleIdList": ["10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H"]}, {"Citation": "Hevener K.E., Zhao W., Ball D.M., Babaoglu K., Qi J., White S.W., Lee R.E. Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J. Chem. Inf. Model. 2009;49:444. doi: 10.1021/CI800293N.", "ArticleIdList": ["10.1021/CI800293N", "PMC2788795", "19434845"]}, {"Citation": "Hsu J.L., Martinis S.A. A Flexible peptide tether controls accessibility of a unique C-terminal RNA-binding domain in leucyl-tRNA synthetases. J. Mol. Biol. 2008;376:482\u2013491. doi: 10.1016/J.JMB.2007.11.065.", "ArticleIdList": ["10.1016/J.JMB.2007.11.065", "PMC2270793", "18155724"]}, {"Citation": "Huang W., Lu S., Huang Z., Liu X., Mou L., Luo Y., Zhao Y., Liu Y., Chen Z., Hou T., Zhang J. Allosite: a method for predicting allosteric sites. Bioinformatics. 2013;29:2357\u20132359. doi: 10.1093/BIOINFORMATICS/BTT399.", "ArticleIdList": ["10.1093/BIOINFORMATICS/BTT399", "23842804"]}, {"Citation": "Hunter J.D. Comput Sci Eng; 2007. Matplotlib: A 2D Graphics Environment, Computing in Science & Engineering."}, {"Citation": "Hussain T., Yogavel M., Sharma A. Inhibition of protein synthesis and malaria parasite development by drug targeting of methionyl-tRNA synthetases. Antimicrob. Agents Chemother. 2015;59:1856\u20131867. doi: 10.1128/AAC.02220-13/SUPPL_FILE/ZAC999103811SO1.PDF.", "ArticleIdList": ["10.1128/AAC.02220-13/SUPPL_FILE/ZAC999103811SO1.PDF", "PMC4356764", "25583729"]}, {"Citation": "Istvan E.S., Guerra F., Abraham M., Huang K.-S., Rocamora F., Zhao H., Xu L., Pasaje C., Kumpornsin K., Luth M.R., Cui H., Yang T., Diaz S.P., Gomez-Lorenzo M.G., Qahash T., Mittal N., Ottilie S., Niles J., Lee M.C.S., Llinas M., Kato N., Okombo J., Fidock D.A., Schimmel P., Gamo F.J., Goldberg D.E., Winzeler E.A. Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target. Sci. Transl. Med. 2023;15 doi: 10.1126/SCITRANSLMED.ADC9249.", "ArticleIdList": ["10.1126/SCITRANSLMED.ADC9249", "PMC10286833", "36888694"]}, {"Citation": "Jackson K.E., Pham J.S., Kwek M., De Silva N.S., Allen S.M., Goodman C.D., McFadden G.I., Ribas de Pouplana L., Ralph S.A. Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum. Int. J. Parasitol. 2012;42:177\u2013186. doi: 10.1016/J.IJPARA.2011.11.008.", "ArticleIdList": ["10.1016/J.IJPARA.2011.11.008", "22222968"]}, {"Citation": "Jaillon P., Drici M. Recent antiarrhythmic drugs. Am. J. Cardiol. 1989;64 doi: 10.1016/0002-9149(89)91203-4.", "ArticleIdList": ["10.1016/0002-9149(89)91203-4", "2688391"]}, {"Citation": "Jain V., Yogavel M., Oshima Y., Kikuchi H., Touquet B., Hakimi M.A., Sharma A. Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis. Structure. 2015;23:819\u2013829. doi: 10.1016/J.STR.2015.02.011.", "ArticleIdList": ["10.1016/J.STR.2015.02.011", "25817387"]}, {"Citation": "Jain V., Yogavel M., Sharma A. Dimerization of arginyl-tRNA synthetase by free heme drives its inactivation in plasmodium falciparum. Structure. 2016;24:1476\u20131487. doi: 10.1016/J.STR.2016.06.018.", "ArticleIdList": ["10.1016/J.STR.2016.06.018", "27502052"]}, {"Citation": "Jim\u00e9nez J., Doerr S., Mart\u00ednez-Rosell G., Rose A.S., De Fabritiis G. DeepSite: protein-binding site predictor using 3D-convolutional neural networks. Bioinformatics. 2017;33:3036\u20133042. doi: 10.1093/BIOINFORMATICS/BTX350.", "ArticleIdList": ["10.1093/BIOINFORMATICS/BTX350", "28575181"]}, {"Citation": "Kim H.S., Cha S.Y., Jo C.H., Han A., Hwang K.Y. The crystal structure of arginyl-tRNA synthetase from Homo sapiens. FEBS Lett. 2014;588:2328\u20132334. doi: 10.1016/J.FEBSLET.2014.05.027.", "ArticleIdList": ["10.1016/J.FEBSLET.2014.05.027", "24859084"]}, {"Citation": "Kim D.K., Lee H.J., Kong J., Cho H.Y., Kim S., Kang B.S. Structural basis for the dynamics of human methionyl-tRNA synthetase in multi-tRNA synthetase complexes. Nucleic Acids Res. 2021;49:6549. doi: 10.1093/NAR/GKAB453.", "ArticleIdList": ["10.1093/NAR/GKAB453", "PMC8216282", "34086935"]}, {"Citation": "Kleczko E.K., Kwak J.W., Schenk E.L., Nemenoff R.A. Targeting the complement pathway as a therapeutic strategy in lung cancer. Front. Immunol. 2019;10 doi: 10.3389/FIMMU.2019.00954.", "ArticleIdList": ["10.3389/FIMMU.2019.00954", "PMC6522855", "31134065"]}, {"Citation": "Koh C.Y., Kim J.E., Shibata S., Ranade R.M., Yu M., Liu J., Gillespie J.R., Buckner F.S., Verlinde C.L.M.J., Fan E., Hol W.G.J. Distinct states of methionyl-tRNA synthetase indicates inhibitor binding by conformational selection. Structure. 2012;20:1681. doi: 10.1016/J.STR.2012.07.011.", "ArticleIdList": ["10.1016/J.STR.2012.07.011", "PMC3472110", "22902861"]}, {"Citation": "Konno M., Sumida T., Uchikawa E., Mori Y., Yanagisawa T., Sekine S.I., Yokoyama S. Modeling of tRNA-assisted mechanism of Arg activation based on a structure of Arg-tRNA synthetase, tRNA, and an ATP analog (ANP) FEBS J. 2009;276:4763\u20134779. doi: 10.1111/J.1742-4658.2009.07178.X.", "ArticleIdList": ["10.1111/J.1742-4658.2009.07178.X", "19656186"]}, {"Citation": "Krauer N., Rauscher R., Polacek N. tRNA synthetases are recruited to yeast ribosomes by rRNA expansion segment 7L but do not require association for functionality. Noncoding RNA. 2021;7 doi: 10.3390/NCRNA7040073.", "ArticleIdList": ["10.3390/NCRNA7040073", "PMC8628890", "34842814"]}, {"Citation": "Kriv\u00e1k R., Hoksza D. P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure. J. Cheminf. 2018;10:1\u201312. doi: 10.1186/S13321-018-0285-8/TABLES/4.", "ArticleIdList": ["10.1186/S13321-018-0285-8/TABLES/4", "PMC6091426", "30109435"]}, {"Citation": "Lagarde N., Zagury J.F., Montes M. Benchmarking data sets for the evaluation of virtual ligand screening methods: review and perspectives. J. Chem. Inf. Model. 2015;55:1297\u20131307. doi: 10.1021/acs.jcim.5b00090.", "ArticleIdList": ["10.1021/acs.jcim.5b00090", "26038804"]}, {"Citation": "Lambros C., Vanderberg J.P. Synchronization of plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 1979;65:418\u2013420. doi: 10.2307/3280287.", "ArticleIdList": ["10.2307/3280287", "383936"]}, {"Citation": "Lin L., Hale S.P., Schimmel P. Aminoacylation error correction. Nature. 1996;384:33\u201334. doi: 10.1038/384033B0.", "ArticleIdList": ["10.1038/384033B0", "8900273"]}, {"Citation": "Liu C., Sanders J.M., Pascal J.M., Hou Y.M. Adaptation to tRNA acceptor stem structure by flexible adjustment in the catalytic domain of class I tRNA synthetases. RNA. 2012;18:213. doi: 10.1261/RNA.029983.111.", "ArticleIdList": ["10.1261/RNA.029983.111", "PMC3264908", "22184460"]}, {"Citation": "Liu R.J., Long T., Li H., Zhao J., Li J., Wang M., Palencia A., Lin J., Cusack S., Wang E.D. Molecular basis of the multifaceted functions of human leucyl-tRNA synthetase in protein synthesis and beyond. Nucleic Acids Res. 2020;48:4946\u20134959. doi: 10.1093/NAR/GKAA189.", "ArticleIdList": ["10.1093/NAR/GKAA189", "PMC7229842", "32232361"]}, {"Citation": "Lobanov M.I., Bogatyreva N.S., Galzitskaia O.V. Radius of gyration is indicator of compactness of protein structure. Mol. Biol. 2008;42:701\u2013706. doi: 10.1134/S0026893308040195.", "ArticleIdList": ["10.1134/S0026893308040195", "18856071"]}, {"Citation": "Manickam Y., Chaturvedi R., Babbar P., Malhotra N., Jain V., Sharma A. Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum. Drug Discov. Today. 2018;23:1233\u20131240. doi: 10.1016/J.DRUDIS.2018.01.050.", "ArticleIdList": ["10.1016/J.DRUDIS.2018.01.050", "29408369"]}, {"Citation": "Martin R.E., Shafik S.H., Richards S.N. Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite. Curr. Opin. Pharmacol. 2018;42:71\u201380. doi: 10.1016/J.COPH.2018.07.010.", "ArticleIdList": ["10.1016/J.COPH.2018.07.010", "30142480"]}, {"Citation": "Mart\u00ednez-Rosell G., Giorgino T., De Fabritiis G. PlayMolecule ProteinPrepare: a web application for protein preparation for molecular dynamics simulations. J. Chem. Inf. Model. 2017;57:1511\u20131516. doi: 10.1021/ACS.JCIM.7B00190/ASSET/IMAGES/LARGE/CI-2017-00190T_0004.", "ArticleIdList": ["10.1021/ACS.JCIM.7B00190/ASSET/IMAGES/LARGE/CI-2017-00190T_0004", "28594549"]}, {"Citation": "McCammon J.A. Protein dynamics. Rep. Prog. Phys. 1984;47:1. doi: 10.1088/0034-4885/47/1/001.", "ArticleIdList": ["10.1088/0034-4885/47/1/001"]}, {"Citation": "McKinney W. Pandas: a foundational Python library for data analysis and statistics. Python High Perform. Sci. Comput. 2011;14(9):1\u20139."}, {"Citation": "Moen S.O., Edwards T.E., Dranow D.M., Clifton M.C., Sankaran B., Van Voorhis W.C., Sharma A., Manoil C., Staker B.L., Myler P.J., Lorimer D.D. Ligand co-crystallization of aminoacyl-tRNA synthetases from infectious disease organisms. Sci. Rep. 2017;7 doi: 10.1038/S41598-017-00367-6.", "ArticleIdList": ["10.1038/S41598-017-00367-6", "PMC5428304", "28303005"]}, {"Citation": "Musyoka T., Bishop \u00d6.T. South African Abietane Diterpenoids and their analogs as potential antimalarials: novel insights from hybrid computational approaches. Molecules. 2019;24 doi: 10.3390/MOLECULES24224036.", "ArticleIdList": ["10.3390/MOLECULES24224036", "PMC6891524", "31703388"]}, {"Citation": "Mysinger M.M., Carchia M., Irwin J.J., Shoichet B.K. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J. Med. Chem. 2012;55:6582\u20136594. doi: 10.1021/JM300687E.", "ArticleIdList": ["10.1021/JM300687E", "PMC3405771", "22716043"]}, {"Citation": "Nakama T., Nureki O., Yokoyama S. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. J. Biol. Chem. 2001;276:47387\u201347393. doi: 10.1074/JBC.M109089200.", "ArticleIdList": ["10.1074/JBC.M109089200", "11584022"]}, {"Citation": "Nakanishi K., Ogiso Y., Nakama T., Fukai S., Nureki O. Structural basis for anticodon recognition by methionyl-tRNA synthetase. Nat. Struct. Mol. Biol. 2005;12:931\u2013932. doi: 10.1038/NSMB988.", "ArticleIdList": ["10.1038/NSMB988", "16155581"]}, {"Citation": "Newberry K.J., Hou Y.M., Perona J.J. Structural origins of amino acid selection without editing by cysteinyl-tRNA synthetase. EMBO J. 2002;21:2778. doi: 10.1093/EMBOJ/21.11.2778.", "ArticleIdList": ["10.1093/EMBOJ/21.11.2778", "PMC126036", "12032090"]}, {"Citation": "Ngan C.H., Bohnuud T., Mottarella S.E., Beglov D., Villar E.A., Hall D.R., Kozakov D., Vajda S. FTMAP: extended protein mapping with user-selected probe molecules. Nucleic Acids Res. 2012;40:W271. doi: 10.1093/NAR/GKS441.", "ArticleIdList": ["10.1093/NAR/GKS441", "PMC3394268", "22589414"]}, {"Citation": "Nyamai D.W., Tastan Bishop \u00d6. Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study. Malar. J. 2019;18(1 18):1\u201327. doi: 10.1186/S12936-019-2665-6. 2019.", "ArticleIdList": ["10.1186/S12936-019-2665-6", "PMC6366043", "30728021"]}, {"Citation": "Nyamai D.W., Tastan Bishop \u00d6. Identification of selective novel hits against plasmodium falciparum prolyl tRNA synthetase active site and a predicted allosteric site using in silico approaches. Int. J. Mol. Sci. 2020;21:3803. doi: 10.3390/IJMS21113803.", "ArticleIdList": ["10.3390/IJMS21113803", "PMC7312540", "32471245"]}, {"Citation": "Nzila A., Mwai L. In vitro selection of Plasmodium falciparum drug-resistant parasite lines. J. Antimicrob. Chemother. 2010;65:390. doi: 10.1093/JAC/DKP449.", "ArticleIdList": ["10.1093/JAC/DKP449", "PMC2818104", "20022938"]}, {"Citation": "Olotu F.A., Omolabi K.F., Soliman M.E.S. Leaving no stone unturned: allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain. Inform. Med. Unlocked. 2020;21 doi: 10.1016/j.imu.2020.100451.", "ArticleIdList": ["10.1016/j.imu.2020.100451", "PMC7561517", "33083517"]}, {"Citation": "Owens C., Pugmire B., Salness T., Culbertson V., Force R., Cady P., Steiner J. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data. Clin. Therapeut. 2007;29:2222\u20132225. doi: 10.1016/J.CLINTHERA.2007.10.003.", "ArticleIdList": ["10.1016/J.CLINTHERA.2007.10.003", "18042478"]}, {"Citation": "Pang Y.L.J., Poruri K., Martinis S.A. tRNA synthetase: tRNA Aminoacylation and beyond. Wiley Interdiscip. Rev. RNA. 2014;5:461. doi: 10.1002/WRNA.1224.", "ArticleIdList": ["10.1002/WRNA.1224", "PMC4062602", "24706556"]}, {"Citation": "Paz M.M., Zhang X., Lu J., Holmgren A. A new mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase. Chem. Res. Toxicol. 2012;25:1502\u20131511. doi: 10.1021/TX3002065.", "ArticleIdList": ["10.1021/TX3002065", "22694104"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Pham J.S., Sakaguchi R., Yeoh L.M., De Silva N.S., Mcfadden G.I., Hou Y.M., Ralph S.A. A dual-targeted aminoacyl-tRNA synthetase in Plasmodium falciparum charges cytosolic and apicoplast tRNACys. Biochem. J. 2014;458:513\u2013523. doi: 10.1042/BJ20131451.", "ArticleIdList": ["10.1042/BJ20131451", "24428730"]}, {"Citation": "Pluijm R., van der Amaratunga C., Dhorda M., Dondorp A. Triple artemisinin-based combination therapies for malaria\u2014a new paradigm? Trends Parasitol. 2021;37:15\u201324.", "ArticleIdList": ["33060063"]}, {"Citation": "RDKit: Open-source cheminformatics. https://www.rdkit.org,n.d.Open-sourcecheminformatics."}, {"Citation": "Reddy T.P., Choi D.S., Anselme A.C., Qian W., Chen W., Lantto J., Horak I.D., Kragh M., Chang J.C., Rosato R.R. Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs. Breast Cancer Res. 2020;22:48. doi: 10.1186/S13058-020-01280-Z.", "ArticleIdList": ["10.1186/S13058-020-01280-Z", "PMC7227035", "32414394"]}, {"Citation": "Ricklin D., Lambris J.D. Complement-targeted therapeutics. Nat. Biotechnol. 2007;25:1265\u20131275. doi: 10.1038/NBT1342.", "ArticleIdList": ["10.1038/NBT1342", "PMC2966895", "17989689"]}, {"Citation": "Rock F.L., Mao W., Yaremchuk A., Tukalo M., Cr\u00e9pin T., Zhou H., Zhang Y.K., Hernandez V., Akama T., Baker S.J., Plattner J.J., Shapiro L., Martinis S.A., Benkovic S.J., Cusack S., Alley M.R.K. An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site. Science. 2007;316:1759\u20131761. doi: 10.1126/SCIENCE.1142189.", "ArticleIdList": ["10.1126/SCIENCE.1142189", "17588934"]}, {"Citation": "Roe D.R., Cheatham III T.E. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theor. Comput. 2013;9:3084\u20133095. doi: 10.1021/ct400341p.", "ArticleIdList": ["10.1021/ct400341p", "26583988"]}, {"Citation": "Sanner M.F. Python: a programming language for software integration and development. J. Mol. Graph. Model. 1999;17:57\u201361.", "ArticleIdList": ["10660911"]}, {"Citation": "Schimmel P., Ribas De Pouplana L. Footprints of aminoacyl-tRNA synthetases are everywhere. Trends Biochem. Sci. 2000;25:207\u2013209. doi: 10.1016/S0968-0004(00)01553-X.", "ArticleIdList": ["10.1016/S0968-0004(00)01553-X", "10782085"]}, {"Citation": "Schulman L.H., Pelka H. Recognition of tRNAs by aminoacyl-tRNA synthetases: Escherichia coli tRNA(Met) and E. coli methionyl-tRNA synthetase. Fed. Proc. 1984;43:2977\u20132980.", "ArticleIdList": ["6389181"]}, {"Citation": "Seiradake E., Mao W., Hernandez V., Baker S.J., Plattner J.J., Alley M.R.K., Cusack S. Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: a structural basis for the rational design of antifungal benzoxaboroles. J. Mol. Biol. 2009;390:196\u2013207. doi: 10.1016/J.JMB.2009.04.073.", "ArticleIdList": ["10.1016/J.JMB.2009.04.073", "19426743"]}, {"Citation": "Sheik Amamuddy O., Glenister M., Tshabalala T., Tastan Bishop \u00d6. MDM-TASK-web: MD-TASK and MODE-TASK web server for analyzing protein dynamics. Comput. Struct. Biotechnol. J. 2021;19:5059\u20135071. doi: 10.1016/J.CSBJ.2021.08.043.", "ArticleIdList": ["10.1016/J.CSBJ.2021.08.043", "PMC8455658", "34589183"]}, {"Citation": "Sherlin L.D., Bullock T.L., Newberry K.J., Lipman R.S.A., Hou Y.M., Beijer B., Sproat B.S., Perona J.J. Influence of transfer RNA tertiary structure on aminoacylation efficiency by glutaminyl and cysteinyl-tRNA synthetases. J. Mol. Biol. 2000;299:431\u2013446. doi: 10.1006/jmbi.2000.3749.", "ArticleIdList": ["10.1006/jmbi.2000.3749", "10860750"]}, {"Citation": "Siddiqui F.A., Liang X., Cui L. Plasmodium falciparum resistance to ACTs: emergence, mechanisms, and outlook. Int. J. Parasitol. Drugs Drug Resist. 2021;16:102\u2013118. doi: 10.1016/J.IJPDDR.2021.05.007.", "ArticleIdList": ["10.1016/J.IJPDDR.2021.05.007", "PMC8188179", "34090067"]}, {"Citation": "Sievers F., Higgins D.G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 2018;27:135\u2013145. doi: 10.1002/PRO.3290.", "ArticleIdList": ["10.1002/PRO.3290", "PMC5734385", "28884485"]}, {"Citation": "Silvian L.F., Wang J., Steitz T.A. Insights into editing from an Ile-tRNA synthetase structure with tRNA(Ile) and mupirocin. Science. 1999;285(1979):1074\u20131077. doi: 10.1126/SCIENCE.285.5430.1074/ASSET/03ED5869-DF88-4424-8031-FD169DB8F0D7/ASSETS/GRAPHIC/SE3197742003.", "ArticleIdList": ["10.1126/SCIENCE.285.5430.1074/ASSET/03ED5869-DF88-4424-8031-FD169DB8F0D7/ASSETS/GRAPHIC/SE3197742003", "10446055"]}, {"Citation": "Singh A., Rosenthal P.J. Comparison of efficacies of cysteine protease inhibitors against five strains of plasmodium falciparum. Antimicrob. Agents Chemother. 2001;45:949\u2013951. doi: 10.1128/AAC.45.3.949-951.2001.", "ArticleIdList": ["10.1128/AAC.45.3.949-951.2001", "PMC90401", "11181388"]}, {"Citation": "Smilkstein M., Sriwilaijaroen N., Kelly J.X., Wilairat P., Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 2004;48:1803\u20131806. doi: 10.1128/AAC.48.5.1803-1806.2004.", "ArticleIdList": ["10.1128/AAC.48.5.1803-1806.2004", "PMC400546", "15105138"]}, {"Citation": "Snodgrass R.G., Collier A.C., Coon A.E., Pritsos C.A. Mitomycin C inhibits ribosomal RNA. J. Biol. Chem. 2010;285:19068\u201319075. doi: 10.1074/jbc.m109.040477.", "ArticleIdList": ["10.1074/jbc.m109.040477", "PMC2885185", "20418373"]}, {"Citation": "Sonoiki E., Palencia A., Guo D., Ahyong V., Dong C., Li X., Hernandez V.S., Zhang Y.K., Choi W., Gut J., Legac J., Cooper R., Alley M.R.K., Freund Y.R., DeRisi J., Cusack S., Rosenthal P.J. Antimalarial benzoxaboroles target plasmodium falciparum leucyl-tRNA synthetase. Antimicrob. Agents Chemother. 2016;60:4886\u20134895. doi: 10.1128/AAC.00820-16.", "ArticleIdList": ["10.1128/AAC.00820-16", "PMC4958189", "27270277"]}, {"Citation": "Soo V., Kwan B., Quezada H., Castillo-Ju\u00e1rez I., P\u00e9rez-Eretza B., Garc\u00eda-Contreras S., Mart\u00ednez-V\u00e1zquez M., Wood T., Garc\u00eda-Contreras R. Repurposing of anticancer drugs for the treatment of bacterial infections. Curr. Top. Med. Chem. 2017;17:1157\u20131176. doi: 10.2174/1568026616666160930131737.", "ArticleIdList": ["10.2174/1568026616666160930131737", "27697046"]}, {"Citation": "Starzyk R.M., Webster T.A., Schimmel P. Evidence for dispensable sequences inserted into a nucleotide fold. Science. 1987;237:1614\u20131618. doi: 10.1126/SCIENCE.3306924.", "ArticleIdList": ["10.1126/SCIENCE.3306924", "3306924"]}, {"Citation": "The PyMOL Molecular Graphics System, Version 2.0 Schr\u00f6dinger, L., n.D. The PyMOL Molecular Graphics System, Version 2.0 Schr\u00f6dinger, LLC."}, {"Citation": "Tolou-Ghamari Z., Zare M., Habibabadi J.M., Najafi M.R. A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J. Res. Med. Sci. 2013;18", "ArticleIdList": ["PMC3743329", "23961295"]}, {"Citation": "Tomasz M. Mitomycin C: small, fast and deadly (but very selective) Chem. Biol. 1995;2:575\u2013579. doi: 10.1016/1074-5521(95)90120-5.", "ArticleIdList": ["10.1016/1074-5521(95)90120-5", "9383461"]}, {"Citation": "Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 1976;193:673\u2013675. doi: 10.1126/SCIENCE.781840. 1979.", "ArticleIdList": ["10.1126/SCIENCE.781840", "781840"]}, {"Citation": "Van Der Walt S., Colbert S.C., Varoquaux G. The NumPy array: a structure for efficient numerical computation. Comput. Sci. Eng. 2011 doi: 10.1109/MCSE.2011.37.", "ArticleIdList": ["10.1109/MCSE.2011.37"]}, {"Citation": "Vidler L.R., Brown N., Knapp S., Hoelder S. Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites. J. Med. Chem. 2012;55:7346\u20137359. doi: 10.1021/JM300346W.", "ArticleIdList": ["10.1021/JM300346W", "PMC3441041", "22788793"]}, {"Citation": "Waskom M. seaborn: statistical data visualization. J. Open Source Softw. 2021 doi: 10.21105/joss.03021.", "ArticleIdList": ["10.21105/joss.03021"]}, {"Citation": "Webb B., Sali A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinformatics. 2016;54(5.6) doi: 10.1002/CPBI.3. 1-5.6.37.", "ArticleIdList": ["10.1002/CPBI.3", "PMC5031415", "27322406"]}, {"Citation": "Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36 doi: 10.1093/NAR/GKM958.", "ArticleIdList": ["10.1093/NAR/GKM958", "PMC2238889", "18048412"]}, {"Citation": "Yi J., Cai Z., Qiu H., Lu F., Luo Z., Chen B., Gu Q., Xu J., Zhou H. Fragment screening and structural analyses highlight the ATP-assisted ligand binding for inhibitor discovery against type 1 methionyl-tRNA synthetase. Nucleic Acids Res. 2022;50:4755. doi: 10.1093/NAR/GKAC285.", "ArticleIdList": ["10.1093/NAR/GKAC285", "PMC9071491", "35474479"]}, {"Citation": "Ylilauri M., Pentik\u00e4inen O.T. MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions. J. Chem. Inf. Model. 2013;53:2626\u20132633. doi: 10.1021/ci4002475.", "ArticleIdList": ["10.1021/ci4002475", "23988151"]}]}], "History": [{"Year": "2024", "Month": "3", "Day": "10"}, {"Year": "2024", "Month": "5", "Day": "11"}, {"Year": "2024", "Month": "5", "Day": "16"}, {"Year": "2024", "Month": "8", "Day": "9", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "29", "Hour": "0", "Minute": "49"}, {"Year": "2024", "Month": "5", "Day": "28", "Hour": "18", "Minute": "17"}, {"Year": "2024", "Month": "5", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38805932", "PMC11152978", "10.1016/j.ijpddr.2024.100548", "S2211-3207(24)00029-0"]}}]}